thiophenes has been researched along with bupropion in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Leonard, BE | 1 |
| Lucki, I; Rénéric, JP | 1 |
| Connoley, IP; Harrison, J; Heal, DJ; Liu, YL; Stock, MJ | 1 |
| Almási, J; Rihmer, Z | 1 |
| Burns, AM; Fava, M; Fisher, LB; Homberger, CH; Iosifescu, DV; Kinrys, G; Mischoulon, D; Papakostas, GI; Worthington, JJ | 1 |
| Ernest, CS; Farid, NA; Li, YG; Payne, CD; Salazar, DE; Small, DS; Winters, KJ | 1 |
| Hawley, P | 1 |
| Ancrenaz, V; Bosilkovska, M; Daali, Y; Dayer, P; Desmeules, J | 1 |
| Bogetto, F; Maina, G; Rigardetto, S; Rosso, G | 1 |
| Dersch, R; Voderholzer, U; Zwernemann, S | 1 |
| Dhamee, MS; Gollapudy, S; Kumar, V | 1 |
| De Berardis, D; De Pasquale, C; Fornaro, M; Fornaro, P; Iasevoli, F; Martino, M; Mattei, C; Mungo, S; Prestia, D; Vinciguerra, V | 1 |
| Addepalli, V; Kale, PP | 1 |
| Baker, RA; Fava, M; Matsushima, Y; Okame, T; Perry, P; Weiller, E | 1 |
| Aladeen, T; Capote, H; Lee, Y; McIntyre, RS; Rainka, M; Rong, C; Westphal, E | 1 |
| Chan, E; Kang, J; Liu, S; Tian, X; Wang, Z; Zhang, X; Zhao, Y | 1 |
2 review(s) available for thiophenes and bupropion
| Article | Year |
|---|---|
New approaches to the treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Brain; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Dopamine; Duloxetine Hydrochloride; Humans; Receptors, Dopamine; Receptors, GABA; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 1996 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
4 trial(s) available for thiophenes and bupropion
| Article | Year |
|---|---|
Prasugrel, a new thienopyridine antiplatelet drug, weakly inhibits cytochrome P450 2B6 in humans.
Topics: Adolescent; Adult; Area Under Curve; Bupropion; Chromatography, Liquid; Cross-Over Studies; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Interactions; Half-Life; Humans; Male; Middle Aged; Molecular Structure; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prodrugs; Pyridines; Tandem Mass Spectrometry; Thiophenes; Time Factors | 2008 |
A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression.
Topics: Adult; Antidepressive Agents; Bupropion; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Single-Blind Method; Thiophenes | 2012 |
Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Depression; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Thiophenes; Young Adult | 2014 |
Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
Topics: Antidepressive Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Cognition; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Impulsive Behavior; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Sleep; Thiophenes; Treatment Outcome | 2017 |
10 other study(ies) available for thiophenes and bupropion
| Article | Year |
|---|---|
Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Cyclopropanes; Desipramine; Duloxetine Hydrochloride; Fluoxetine; Male; Milnacipran; Motor Activity; Rats; Rats, Sprague-Dawley; Thiophenes | 1998 |
Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors.
Topics: Animals; Body Temperature; Body Temperature Regulation; Bupropion; Conditioning, Operant; Cyclobutanes; Duloxetine Hydrochloride; Eating; Female; Hot Temperature; Neurotransmitter Uptake Inhibitors; Oxygen Consumption; Rats; Rats, Wistar; Serotonin; Thiophenes | 2002 |
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
Topics: Adult; Antidepressive Agents; Bupropion; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Thiophenes; Treatment Outcome | 2006 |
Nontricyclic antidepressants for neuropathic pain #187.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Duloxetine Hydrochloride; Humans; Neuralgia; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients.
Topics: Bupropion; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; In Vitro Techniques; Inactivation, Metabolic; Metabolic Networks and Pathways; Microsomes, Liver; Models, Biological; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Ritonavir; Thiophenes | 2011 |
Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion.
Topics: Adrenergic Uptake Inhibitors; Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder, Major; Duloxetine Hydrochloride; Electroconvulsive Therapy; Electroencephalography; Humans; Male; Seizures; Status Epilepticus; Thiophenes | 2011 |
A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion.
Topics: Aged; Analgesics, Opioid; Anesthesia, General; Bupropion; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fentanyl; Humans; Mastectomy; Ondansetron; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiophenes | 2012 |
Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Caffeine; Chromatography, High Pressure Liquid; Drug Interactions; Duloxetine Hydrochloride; Male; Mice; Neurotransmitter Agents; Spectrometry, Fluorescence; Thiophenes | 2014 |
The use of brexpiprazole amongst individuals with insufficient outcomes with aripiprazole or bupropion: A case series.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; New York; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Thiophenes; Treatment Outcome; Young Adult | 2018 |
Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
Topics: Bupropion; Computer Simulation; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2B6 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Glucuronosyltransferase; Humans; In Vitro Techniques; Kinetics; Mephenytoin; Microsomes, Liver; Phenylacetates; Platelet Aggregation Inhibitors; Thiophenes | 2022 |